Implantable shunt or catheter enabling gradual delivery of therapeutic agents

• US 20080051691A1
• Filed: 08/27/2007
• Published: 02/28/2008
• Est. Priority Date: 08/28/2006
• Status: Abandoned Application

• Current Assignee: Wyeth LLC (Pfizer Inc.)
• Original Assignee: Wyeth (Pfizer Inc.)
• Inventors: Cohen, Jonathan Marc, Dragoon, Deborah L.
• Application Number:
  US11/895,770
• Publication Number:
  US 20080051691A1
• Time in Patent Office: Days
• US Class Current: 604/8
• CPC Class Codes: A61K 31/436 the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
• CPC Class Codes: A61L 2300/406 Antibiotics
• CPC Class Codes: A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61M 27/006 Cerebrospinal drainage; Accessories therefor, e.g. valves
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system

Abstract

An implantable catheter or shunt for draining fluid from a body cavity. The catheter or shunt body has a wall structure that carries one or more therapeutic agents in a manner enabling release of the therapeutic agent from the wall structure in situ after surgical implantation of the catheter or shunt body. The therapeutic agent can be gradually released over time to prevent infection, inhibit tissue ingrowths, and/or provide some other desired medicinal purpose. As an example, the therapeutic agent can be rapamycin or an mTOR inhibitor. According to some contemplated embodiments of the present invention, the therapeutic agent carried by the catheter/shunt is rechargeable or refillable in situ so that the therapeutic agent can be gradually released from the catheter/shunt over the expected useful life of the catheter/shunt.

Claims

1. An implantable shunt system for draining fluid from a body cavity, comprising a catheter and at least one therapeutic agent carried by a wall structure of said catheter, said wall structure having an outer peripheral surface and an inner peripheral surface defining a lumen through which fluid is drained from the body cavity, and said wall structure enabling gradual release of said therapeutic agent from said wall structure in situ after implantation of said catheter body.

2. The implantable shunt system according to claim 1, further comprising a means for recharging or refilling the therapeutic agent carried by said wall structure in situ within a patient.

3. The implantable shunt system according to claim 2, further comprising at least one channel extending within said wall structure between said inner and outer peripheral surfaces, said channel containing a supply of said therapeutic agent which is gradually releasable therefrom through at least one of said inner and outer peripheral surfaces.

4. The implantable shunt system according to claim 3, wherein said at least one channel includes an inlet, and wherein said catheter further comprises a reservoir that carries a supply of said therapeutic agent, that is located external of said wall structure and that is in fluid communication with said inlet.

5. The implantable shunt system according to claim 4, further comprising a pump that can be actuated to pump said therapeutic agent from said reservoir into said channel via said inlet.

6. The implantable shunt system according to claim 5, wherein said at least one channel comprises a plurality of adjacent channels extending in a substantially longitudinal direction within said wall structure along a predetermined length of said catheter body.

7. The implantable shunt system according to claim 6, wherein at least selected ones of said channels interconnect at ends thereof so that said therapeutic agent travels in a first direction along a length of one of said channels and in a reverse direction within an adjacent channel.

8. The implantable shunt system according to claim 6, wherein said reservoir includes multiple separate reservoirs each communicating with a different channel and carrying a supply of a different therapeutic agent.

9. The implantable shunt system according to claim 1, wherein said therapeutic agent is an mTOR inhibitor.

10. The implantable shunt system according to claim 9, wherein said therapeutic agent is a rapamycin.

11. The implantable shunt system according to claim 10, wherein said therapeutic agent is selected from the group consisting of rapamycin and CCI-779.

12. The implantable shunt system according to claim 1, wherein multiple different therapeutic agents are carried by said wall structure.

13. The implantable shunt system according to claim 1, wherein said therapeutic agent is provided in a film formed on a surface of said wall structure.

14. The implantable shunt system according to claim 1, wherein said therapeutic agent is impregnated within a material from which said wall structure is formed and is diffusible through said wall structure.

15. The implantable shunt system according to claim 1, wherein said wall structure of is a single-walled tube extruded with hollow channels extending within the single-wall of the tube.

16. The implantable shunt system according to claim 1, wherein said wall structure includes an inner tube defining said lumen through which fluid is drained from the body cavity and an outer tube or jacket supported a spaced distance about said inner tube defining a chamber therebetween for containing a supply of said therapeutic agent.

17. The implantable shunt system according to claim 14, wherein said wall structure includes at least one stabilizer positioned within said chamber to maintain proper spacing between said inner tube and outer tube or jacket or to divide said chamber into multiple separate chambers.

30. A method of draining unwanted bodily fluids in a patient requiring long-term drainage, the method comprising the step of implanting into a patient in need thereof an implantable shunt system according to claim 1.

31. The method according to claim 30, wherein the catheter is adjacent to a biocompatible matrix, said matrix capable of delivering a therapeutic agent over a prolonged period of time.

32. The method according to claim 30, wherein the fluids comprise cerebrospinal fluid.

33. The method according to claim 30, wherein the fluids comprise a carrier and at least one therapeutic agent or metabolites thereof.

34. The method according to claim 33, wherein the therapeutic agent is an mTOR inhibitor.

35. The method according to claim 33, wherein the therapeutic agent is an antibiotic.

18. A cerebrospinal fluid shunt system having a ventricular catheter and drainage shunt interconnected directly or indirectly by a flow control mechanism, one of said ventricular catheter and drainage shunt comprising an elongate body defining a lumen therein for passage of cerebrospinal fluid to or from said flow control mechanism, said body formed by a wall structure carrying at least one therapeutic agent therein or thereon, said wall structure releasing said therapeutic agent in situ after implantation of said shunt system.

19. The cerebrospinal fluid shunt system according to claim 18, further comprising means for recharging or refilling the therapeutic agent carried by said wall structure in situ within a patient.

20. The cerebrospinal fluid shunt system according to claim 18, wherein said therapeutic agent is an mTOR inhibitor.

21. The cerebrospinal fluid shunt system according to claim 20, wherein said mTOR inhibitor is a rapamycin.

22. The cerobrospinal fluid shunt system according to claim 21, wherein the rapamycin is selected from the rapamycin and CCI-779.

23. The cerebrospinal fluid shunt system according to claim 18, wherein said therapeutic agent is provided in a film formed on a surface of said wall structure or is impregnated within a material from which said wall structure is composed and is diffusible through said wall structure.

24. The cerebrospinal fluid shunt system according to claim 18, wherein said wall structure provides an outer peripheral surface of said body and an inner peripheral surface of said body, wherein said inner peripheral surface defines said lumen, and wherein at least one channel extends within said wall structure between said inner and outer peripheral surfaces, said channel containing a supply of said therapeutic agent which is slowly releasable therefrom through at least one of said inner and outer peripheral surfaces.

25. The cerebrospinal fluid shunt system according to claim 24, wherein said at least one channel includes an inlet and an outlet permitting flushing, refilling, recharging or circulating of said supply of therapeutic agent in said channel.

26. The cerebrospinal fluid shunt system according to claim 18, further comprising at least one implantable reservoir carrying a supply of said therapeutic agent, being located external of said wall structure, and being in fluid communication with said inlet and outlet.

27. The cerebrospinal fluid shunt system according to claim 26, further comprising an implantable pump located external of said wall structure and adapted to pump said therapeutic agent from said reservoir into said channel.

28. The cerebrospinal fluid shunt system according to claim 27, wherein said wall structure is an extruded flexible single-walled tube having an array of separate longitudinally-extending channels formed therein.

29. The cerebrospinal fluid shunt system according to claim 27, wherein said wall structure includes an inner tube defining said lumen and an outer jacket that defines said at least one channel therebetween.

36. A method for delivering a therapeutic agent to a patient having hydrocephaly, said method comprising the step of surgically implanting into said patient a cerebrospinal fluid shunt system according to claim 18.